APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nonalcoholic Steatohepatitis Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nonalcoholic Steatohepatitis Treatment Industry Growth and Trends Forecast to 2032

31 December 2025102 pages

Choose your research edition.

Industry ResearchNonalcoholic Steatohepatitis Treatment Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Nonalcoholic Steatohepatitis Treatment Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Nonalcoholic Steatohepatitis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nonalcoholic Steatohepatitis Treatment Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Nonalcoholic Steatohepatitis Treatment Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

According to APO Research, the global Nonalcoholic Steatohepatitis Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nonalcoholic Steatohepatitis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nonalcoholic Steatohepatitis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nonalcoholic Steatohepatitis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Nonalcoholic Steatohepatitis Treatment market include Arena Pharmaceuticals, Arisaph Pharmaceuticals, Cempra Pharmaceuticals, Galectin Therapeutics, Galmed Pharmaceuticals, Genfit, Gilead, Novo Nordisk and Vivus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nonalcoholic Steatohepatitis Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nonalcoholic Steatohepatitis Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nonalcoholic Steatohepatitis Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nonalcoholic Steatohepatitis Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Nonalcoholic Steatohepatitis Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nonalcoholic Steatohepatitis Treatment Market by Company

Arena Pharmaceuticals

Arisaph Pharmaceuticals

Cempra Pharmaceuticals

Galectin Therapeutics

Galmed Pharmaceuticals

Genfit

Gilead

Novo Nordisk

Vivus

AstraZeneca

GSK

Roche

Nonalcoholic Steatohepatitis Treatment Segment by Type

Solid

Liquid

Nonalcoholic Steatohepatitis Treatment Segment by Application

Drug Store

Hospital

Hospital Pharmacy

Mail Order Pharmacy

Diagnostic Center

Specialized Clinic

Nonalcoholic Steatohepatitis Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nonalcoholic Steatohepatitis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nonalcoholic Steatohepatitis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nonalcoholic Steatohepatitis Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Nonalcoholic Steatohepatitis Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Nonalcoholic Steatohepatitis Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Nonalcoholic Steatohepatitis Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Nonalcoholic Steatohepatitis Treatment Market Share by Region (2021-2026) Table 4. Global Nonalcoholic Steatohepatitis Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Nonalcoholic Steatohepatitis Treatment Market Share by Region (2027-2032) Table 6. Global Nonalcoholic Steatohepatitis Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Nonalcoholic Steatohepatitis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Nonalcoholic Steatohepatitis Treatment Market Size Share by Type (2021-2026) Table 9. Global Nonalcoholic Steatohepatitis Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Nonalcoholic Steatohepatitis Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Nonalcoholic Steatohepatitis Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Nonalcoholic Steatohepatitis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Nonalcoholic Steatohepatitis Treatment Market Size Share by Application (2021-2026) Table 24. Global Nonalcoholic Steatohepatitis Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Nonalcoholic Steatohepatitis Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Nonalcoholic Steatohepatitis Treatment Industry Trends Table 37. Nonalcoholic Steatohepatitis Treatment Industry Drivers Table 38. Nonalcoholic Steatohepatitis Treatment Industry Opportunities and Challenges Table 39. Nonalcoholic Steatohepatitis Treatment Industry Restraints Table 40. Global Nonalcoholic Steatohepatitis Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Nonalcoholic Steatohepatitis Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Nonalcoholic Steatohepatitis Treatment Key Company Headquarters & Area Served Table 44. Global Nonalcoholic Steatohepatitis Treatment Company, Product Type & Application Table 45. Global Nonalcoholic Steatohepatitis Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Nonalcoholic Steatohepatitis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Arena Pharmaceuticals Company Information Table 49. Arena Pharmaceuticals Business Overview Table 50. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 52. Arena Pharmaceuticals Recent Development Table 53. Arisaph Pharmaceuticals Company Information Table 54. Arisaph Pharmaceuticals Business Overview Table 55. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 57. Arisaph Pharmaceuticals Recent Development Table 58. Cempra Pharmaceuticals Company Information Table 59. Cempra Pharmaceuticals Business Overview Table 60. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 62. Cempra Pharmaceuticals Recent Development Table 63. Galectin Therapeutics Company Information Table 64. Galectin Therapeutics Business Overview Table 65. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 67. Galectin Therapeutics Recent Development Table 68. Galmed Pharmaceuticals Company Information Table 69. Galmed Pharmaceuticals Business Overview Table 70. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 72. Galmed Pharmaceuticals Recent Development Table 73. Genfit Company Information Table 74. Genfit Business Overview Table 75. Genfit Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Genfit Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 77. Genfit Recent Development Table 78. Gilead Company Information Table 79. Gilead Business Overview Table 80. Gilead Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Gilead Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 82. Gilead Recent Development Table 83. Novo Nordisk Company Information Table 84. Novo Nordisk Business Overview Table 85. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 87. Novo Nordisk Recent Development Table 88. Vivus Company Information Table 89. Vivus Business Overview Table 90. Vivus Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Vivus Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 92. Vivus Recent Development Table 93. AstraZeneca Company Information Table 94. AstraZeneca Business Overview Table 95. AstraZeneca Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. AstraZeneca Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 97. AstraZeneca Recent Development Table 98. GSK Company Information Table 99. GSK Business Overview Table 100. GSK Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. GSK Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 102. GSK Recent Development Table 103. Roche Company Information Table 104. Roche Business Overview Table 105. Roche Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Roche Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 107. Roche Recent Development Table 108. North America Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Nonalcoholic Steatohepatitis Treatment Market Share by Country (2021-2026) Table 111. North America Nonalcoholic Steatohepatitis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Nonalcoholic Steatohepatitis Treatment Market Share Forecast by Country (2027-2032) Table 113. Europe Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Nonalcoholic Steatohepatitis Treatment Market Share by Country (2021-2026) Table 116. Europe Nonalcoholic Steatohepatitis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Nonalcoholic Steatohepatitis Treatment Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 120. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Share by Country (2021-2026) Table 121. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Share Forecast by Country (2027-2032) Table 123. Latin America Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Latin America Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 125. Latin America Nonalcoholic Steatohepatitis Treatment Market Share by Country (2021-2026) Table 126. Latin America Nonalcoholic Steatohepatitis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Latin America Nonalcoholic Steatohepatitis Treatment Market Share Forecast by Country (2027-2032) Table 128. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021-2026) & (US$ Million) Table 130. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Share by Country (2021-2026) Table 131. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Share Forecast by Country (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Nonalcoholic Steatohepatitis Treatment Product Image Figure 3. Global Nonalcoholic Steatohepatitis Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Nonalcoholic Steatohepatitis Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Nonalcoholic Steatohepatitis Treatment Market Share by Region (2021-2032) Figure 7. North America Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Solid Image Figure 13. Global Solid Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Liquid Image Figure 15. Global Liquid Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Nonalcoholic Steatohepatitis Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Nonalcoholic Steatohepatitis Treatment Market Share by Type 2025 VS 2032 Figure 18. North America Nonalcoholic Steatohepatitis Treatment Market Size Share by Type (2021-2032) Figure 19. Europe Nonalcoholic Steatohepatitis Treatment Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Size Share by Type (2021-2032) Figure 21. Latin America Nonalcoholic Steatohepatitis Treatment Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Market Size Share by Type (2021-2032) Figure 23. Drug Store Image Figure 24. Global Drug Store Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Hospital Image Figure 26. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Hospital Pharmacy Image Figure 28. Global Hospital Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Mail Order Pharmacy Image Figure 30. Global Mail Order Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Diagnostic Center Image Figure 32. Global Diagnostic Center Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Specialized Clinic Image Figure 34. Global Specialized Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Nonalcoholic Steatohepatitis Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Nonalcoholic Steatohepatitis Treatment Market Share by Application 2025 VS 2032 Figure 37. North America Nonalcoholic Steatohepatitis Treatment Market Size Share by Application (2021-2032) Figure 38. Europe Nonalcoholic Steatohepatitis Treatment Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Size Share by Application (2021-2032) Figure 40. Latin America Nonalcoholic Steatohepatitis Treatment Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Nonalcoholic Steatohepatitis Treatment Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Nonalcoholic Steatohepatitis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Nonalcoholic Steatohepatitis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Nonalcoholic Steatohepatitis Treatment Market Share by Country (2021-2032) Figure 47. Europe Nonalcoholic Steatohepatitis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Nonalcoholic Steatohepatitis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Nonalcoholic Steatohepatitis Treatment Market Share by Country (2021-2032) Figure 50. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Share by Country (2021-2032) Figure 53. Latin America Nonalcoholic Steatohepatitis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Nonalcoholic Steatohepatitis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Nonalcoholic Steatohepatitis Treatment Market Share by Country (2021-2032) Figure 56. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Solid
  • Liquid
Applications
  • Drug Store
  • Hospital
  • Hospital Pharmacy
  • Mail Order Pharmacy
  • Diagnostic Center
  • Specialized Clinic
Companies covered
  • Arena Pharmaceuticals
  • Arisaph Pharmaceuticals
  • Cempra Pharmaceuticals
  • Galectin Therapeutics
  • Galmed Pharmaceuticals
  • Genfit
  • Gilead
  • Novo Nordisk
  • Vivus
  • AstraZeneca
  • GSK
  • Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Nonalcoholic Steatohepatitis Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Nonalcoholic Steatohepatitis Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Nonalcoholic Steatohepatitis Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Nonalcoholic Steatohepatitis Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032)
  8. 1.5.1 North America Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (2021-2032)
2 Nonalcoholic Steatohepatitis Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Solid
  3. 2.1.2 Liquid
  4. 2.2 Global Nonalcoholic Steatohepatitis Treatment Market Size by Type
  5. 2.2.1 Global Nonalcoholic Steatohepatitis Treatment Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Nonalcoholic Steatohepatitis Treatment Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Nonalcoholic Steatohepatitis Treatment Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Nonalcoholic Steatohepatitis Treatment Market Size by Regions
  9. 2.3.1 North America Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Type (2021-2026)
3 Nonalcoholic Steatohepatitis Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Drug Store
  3. 3.1.2 Hospital
  4. 3.1.3 Hospital Pharmacy
  5. 3.1.4 Mail Order Pharmacy
  6. 3.1.5 Diagnostic Center
  7. 3.1.6 Specialized Clinic
  8. 3.2 Global Nonalcoholic Steatohepatitis Treatment Market Size by Application
  9. 3.2.1 Global Nonalcoholic Steatohepatitis Treatment Market Size Overview by Application (2021-2032)
  10. 3.2.2 Global Nonalcoholic Steatohepatitis Treatment Historic Market Size Review by Application (2021-2026)
  11. 3.2.3 Global Nonalcoholic Steatohepatitis Treatment Market Size Forecasted by Application (2027-2032)
  12. 3.3 Global Nonalcoholic Steatohepatitis Treatment Market Size by Regions
  13. 3.3.1 North America Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.2 Europe Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Application (2021-2026)
  15. 3.3.3 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Application (2021-2026)
  16. 3.3.4 South America Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Application (2021-2026)
  17. 3.3.5 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Nonalcoholic Steatohepatitis Treatment Industry Trends
  2. 4.2 Nonalcoholic Steatohepatitis Treatment Industry Drivers
  3. 4.3 Nonalcoholic Steatohepatitis Treatment Industry Opportunities and Challenges
  4. 4.4 Nonalcoholic Steatohepatitis Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Nonalcoholic Steatohepatitis Treatment Revenue (2021-2026)
  2. 5.2 Global Nonalcoholic Steatohepatitis Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Nonalcoholic Steatohepatitis Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Nonalcoholic Steatohepatitis Treatment Company, Product Type & Application
  5. 5.5 Global Nonalcoholic Steatohepatitis Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Nonalcoholic Steatohepatitis Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Nonalcoholic Steatohepatitis Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Nonalcoholic Steatohepatitis Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Arena Pharmaceuticals
  2. 6.1.1 Arena Pharmaceuticals Company Information
  3. 6.1.2 Arena Pharmaceuticals Business Overview
  4. 6.1.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio
  6. 6.1.5 Arena Pharmaceuticals Recent Developments
  7. 6.2 Arisaph Pharmaceuticals
  8. 6.2.1 Arisaph Pharmaceuticals Company Information
  9. 6.2.2 Arisaph Pharmaceuticals Business Overview
  10. 6.2.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio
  12. 6.2.5 Arisaph Pharmaceuticals Recent Developments
  13. 6.3 Cempra Pharmaceuticals
  14. 6.3.1 Cempra Pharmaceuticals Company Information
  15. 6.3.2 Cempra Pharmaceuticals Business Overview
  16. 6.3.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio
  18. 6.3.5 Cempra Pharmaceuticals Recent Developments
  19. 6.4 Galectin Therapeutics
  20. 6.4.1 Galectin Therapeutics Company Information
  21. 6.4.2 Galectin Therapeutics Business Overview
  22. 6.4.3 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Product Portfolio
  24. 6.4.5 Galectin Therapeutics Recent Developments
  25. 6.5 Galmed Pharmaceuticals
  26. 6.5.1 Galmed Pharmaceuticals Company Information
  27. 6.5.2 Galmed Pharmaceuticals Business Overview
  28. 6.5.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio
  30. 6.5.5 Galmed Pharmaceuticals Recent Developments
  31. 6.6 Genfit
  32. 6.6.1 Genfit Company Information
  33. 6.6.2 Genfit Business Overview
  34. 6.6.3 Genfit Nonalcoholic Steatohepatitis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Genfit Nonalcoholic Steatohepatitis Treatment Product Portfolio
  36. 6.6.5 Genfit Recent Developments
  37. 6.7 Gilead
  38. 6.7.1 Gilead Company Information
  39. 6.7.2 Gilead Business Overview
  40. 6.7.3 Gilead Nonalcoholic Steatohepatitis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Gilead Nonalcoholic Steatohepatitis Treatment Product Portfolio
  42. 6.7.5 Gilead Recent Developments
  43. 6.8 Novo Nordisk
  44. 6.8.1 Novo Nordisk Company Information
  45. 6.8.2 Novo Nordisk Business Overview
  46. 6.8.3 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Product Portfolio
  48. 6.8.5 Novo Nordisk Recent Developments
  49. 6.9 Vivus
  50. 6.9.1 Vivus Company Information
  51. 6.9.2 Vivus Business Overview
  52. 6.9.3 Vivus Nonalcoholic Steatohepatitis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Vivus Nonalcoholic Steatohepatitis Treatment Product Portfolio
  54. 6.9.5 Vivus Recent Developments
  55. 6.10 AstraZeneca
  56. 6.10.1 AstraZeneca Company Information
  57. 6.10.2 AstraZeneca Business Overview
  58. 6.10.3 AstraZeneca Nonalcoholic Steatohepatitis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 AstraZeneca Nonalcoholic Steatohepatitis Treatment Product Portfolio
  60. 6.10.5 AstraZeneca Recent Developments
  61. 6.11 GSK
  62. 6.11.1 GSK Company Information
  63. 6.11.2 GSK Business Overview
  64. 6.11.3 GSK Nonalcoholic Steatohepatitis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 GSK Nonalcoholic Steatohepatitis Treatment Product Portfolio
  66. 6.11.5 GSK Recent Developments
  67. 6.12 Roche
  68. 6.12.1 Roche Company Information
  69. 6.12.2 Roche Business Overview
  70. 6.12.3 Roche Nonalcoholic Steatohepatitis Treatment Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Roche Nonalcoholic Steatohepatitis Treatment Product Portfolio
  72. 6.12.5 Roche Recent Developments
7 North America
  1. 7.1 North America Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Nonalcoholic Steatohepatitis Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Nonalcoholic Steatohepatitis Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Nonalcoholic Steatohepatitis Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst